Indevus To Price Sanctura At 10% Discount To Pfizer Detrol LA
This article was originally published in The Pink Sheet Daily
Executive Summary
A daily dose of Sanctura – two 20 mg tablets – will carry an average wholesale price of $2.98. Retail pharmacies will begin receiving initial shipments of the incontinence agent over the next week, Indevus said.
You may also be interested in...
Yamanouchi Will Promote Vesicare With 150 Specialty Sales Reps
FDA clears Vesicare for the treatment of overactive bladder. Yamanouchi and co-promotion partner GlaxoSmithKline will launch solifenacin in January 2005, with GSK sales reps handling primary care duties and Yamanouchi reps detailing to urologist and ob/gyns.
Yamanouchi Will Promote Vesicare With 150 Specialty Sales Reps
FDA clears Vesicare for the treatment of overactive bladder. Yamanouchi and co-promotion partner GlaxoSmithKline will launch solifenacin in January 2005, with GSK sales reps handling primary care duties and Yamanouchi reps detailing to urologist and ob/gyns.
Indevus Adds Senior VP-Clinical Development From Praecis
James Shipley, MD, will support medical affairs and post-marketing safety surveillance for the overactive bladder agent Sanctura. He will also evaluate development strategies for pipeline products.